Last Week Was a Keg of Lib Tears and It's Time to Party...
What Dems Are Considering to Enact Their Failed Gerrymandered VA Map Is Totally...
Uh, Kamala, Are You Sure You Want That Report Released?
Bill Maher Highlighted What Used to Be a Dirty Word in American Politics
What This Liberal NYC Woman Said About a Recent Criminal Will Make Your...
The Democrat Money Grab
Here's How Much That Closing Chicago Walgreens Has Lost to Criminals
Ted Lieu Promised Dems Will Make Everything More Expensive If They Retake Power
Can't Barack Obama Learn a New Hobby?
Trump’s Moves for the US Senate Races
The Ties That Bond Marxists and Islamists
Trump's Well Deserved Victory Lap
The Future That Almost Never Was
The Revolution in Direct Democracy in America
State Bar of Arizona Disbarring Conservative Attorney After Exercising His Free Speech
Tipsheet

Meet the First Recipients of the Pfizer Vaccine

Meet the First Recipients of the Pfizer Vaccine
AP Photo/Richard Drewm Fuke

Margaret Keenan, a 90-year-old grandmother who turns 91 next week, became the first person to receive a dose of the Pfizer vaccine on Tuesday. She was given the shot at the UK's University Hospital Coventry at 6:31 a.m. She said she felt "so privileged to be the first person vaccinated against COVID-19."

Advertisement

"It's the best early birthday present I could wish for because it means I can finally look forward to spending time with my family and friends in the New Year after being on my own for most of the year," Keenan remarked.

Here in the U.S., the FDA is meeting on Thursday to discuss Pfizer's emergency authorization request. In clinical trials, the Pfizer vaccine candidate, which was developed in partnership with BioNTech, proved to be 95 percent effective and with "no serious safety concerns," a company statement read.

"The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform," the FDA's agenda for Thursday reads. "On December 10, 2020, the Center for Biologics Evaluation and Research’s (CBER), Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet in open session to discuss Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 in individuals 16 years of age and older."

A second candidate, developed by Moderna, was over 94 percent effective. They too have requested an emergency authorization and the FDA will be meeting about that vaccine on Dec. 17.

Advertisement

"I think there's every chance that we will look back on...(Tuesday) as marking a decisive turning point in the battle against coronavirus," Simon Stevens, the CEO of England's National Health Service, said after the first dose was administered.

By the way, the second person to get a dose of the Pfizer vaccine in the UK is an 81-year-old man named William Shakespeare. Seriously.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement